Literature DB >> 21996573

A double blind randomised trial of IIb or not IIb neck dissections on electromyography, clinical examination, and questionnaire-based outcomes: a feasibility study.

S Parikh1, B M Tedman, B Scott, D Lowe, S N Rogers.   

Abstract

The aim of this double-blind randomised controlled trial was to evaluate the feasibility of a study to compare differences using electromyographic (EMG) or nerve conduction studies (NCS), questionnaires completed by patients, and range of movement, after selective supraomohyoid neck dissection in patients with and without level IIb for node-negative oral cancer. Between January 2006 and July 2008 we recruited 57 previously untreated consecutive patients with node-negative T1 or T2 squamous cell carcinomas (SCC) of the anterior two-thirds of the tongue and floor of the mouth. Thirty-eight patients were randomised (32 unilateral and 6 bilateral dissections) into two groups. Preoperatively and at 6 weeks postoperatively we collected EMG or NCS data on trapezius muscle activity (primary outcome), the University of Washington quality of life scale (UWQoLv4), the neck dissection impairment index (NDII), and range of movement. At 6 months data on range of movement and data from the questionnaires were obtained. There was a greater mean fall in trapezius M-response amplitude for those who had IIb dissected, which suggested that inclusion of this level caused additional morbidity. However, it was not significant for patients who had unilateral dissections or for all necks combined. Changes in M-amplitude from baseline to 6 weeks, and from baseline to 6 months were strongly associated with changes in the shoulder domain of the UWQoL and the NDII, but were less strong for change in range of movement. This feasibility study has shown that a randomised controlled trial (RCT) is achievable. The combination of EMG or NCS with questionnaire data preoperatively and to 6 weeks would suffice and would simplify a new study design.
Copyright © 2011 The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21996573     DOI: 10.1016/j.bjoms.2011.09.007

Source DB:  PubMed          Journal:  Br J Oral Maxillofac Surg        ISSN: 0266-4356            Impact factor:   1.651


  9 in total

1.  The impact on post-operative shoulder function of intraoperative nerve monitoring of cranial nerve XI during modified radical neck dissection.

Authors:  Boštjan Lanišnik; Lidija Žitnik; Primož Levart; Miha Žargi; Zoran Rodi
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-05-26       Impact factor: 2.503

2.  Management of the Neck in Squamous Cell Carcinoma of the Oral Cavity and Oropharynx: ASCO Clinical Practice Guideline.

Authors:  Shlomo A Koyfman; Nofisat Ismaila; Doug Crook; Anil D'Cruz; Cristina P Rodriguez; David J Sher; Damian Silbermins; Erich M Sturgis; Terance T Tsue; Jared Weiss; Sue S Yom; F Christopher Holsinger
Journal:  J Clin Oncol       Date:  2019-02-27       Impact factor: 44.544

3.  Lymph node metastasis in level IIb in oropharyngeal squamous cell carcinoma: a multicentric, longitudinal, retrospective analysis.

Authors:  Carlos Miguel Chiesa-Estomba; Juan David Urazan; Cammaroto Giovanni; Mannelli Giuditta; Molteni Gabriele; Dallari Virginia; R Lechien Jerome; Miguel Mayo-Yanez; José Ángel González-García; Jon Alexander Sistiaga-Suarez; Tucciarone Manuel; Ayad Tareck; Meccariello Giuseppe
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-09-14       Impact factor: 3.236

4.  How is neck dissection performed in Oral and Maxillofacial Surgery? Results of a representative nationwide survey among university and non-university hospitals in Germany.

Authors:  Andreas Pabst; Daniel G E Thiem; Elisabeth Goetze; Alexander K Bartella; Michael T Neuhaus; Jürgen Hoffmann; Alexander-N Zeller
Journal:  Clin Oral Investig       Date:  2021-03-29       Impact factor: 3.573

5.  Intraoperative brief electrical stimulation (BES) for prevention of shoulder dysfunction after oncologic neck dissection: study protocol for a randomized controlled trial.

Authors:  Brittany Barber; Margaret McNeely; K Ming Chan; Rhys Beaudry; Jaret Olson; Jeffrey Harris; Hadi Seikaly; Daniel O'Connell
Journal:  Trials       Date:  2015-05-30       Impact factor: 2.279

6.  Functional outcomes and quality of life after a 6-month early intervention program for oral cancer survivors: a single-arm clinical trial.

Authors:  Yueh-Hsia Chen; Wei-An Liang; Chung-Yin Hsu; Siang-Lan Guo; Shwu-Huei Lien; Hsiao-Jung Tseng; Yuan-Hung Chao
Journal:  PeerJ       Date:  2018-02-21       Impact factor: 2.984

7.  Determining the effectiveness of fibrin sealants in reducing complications in patients undergoing lateral neck dissection (DEFeND): study protocol for a randomised external pilot trial.

Authors:  Mandeep S Bajwa; Stacey Carruthers; Rob Hanson; Richard Jackson; Chris Braithwaite; Mike Edwards; Seema Chauhan; Catrin Tudur Smith; Richard J Shaw; Andrew G Schache
Journal:  Pilot Feasibility Stud       Date:  2020-05-26

Review 8.  Levels of scientific evidence of the quality of life in patients treated for oral cancer.

Authors:  Rocío Barrios; Javier Montero; Miguel-Angel González-Moles; Pilar Baca; Manuel Bravo
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2013-07-01

9.  Contralateral nodal failures in oropharyngeal cancers after TORS and unilateral neck management: a retrospective study.

Authors:  Axel Sahovaler; John J W Lee; Wei Xu; Susie Su; Ali Hosni; Andrew Bayley; David P Goldstein; John R de Almeida
Journal:  J Otolaryngol Head Neck Surg       Date:  2021-12-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.